Blueprint Medicines
BPMC
₹11,273
Share price
0.00%
Change (1 day)
22.01%
Change (1 year)
Categories
Blueprint Medicines (BPMC) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : ₹74.32 Billion
According to Blueprint Medicines 's latest financial reports the company's total liabilities are ₹74.32 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Blueprint Medicines - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | ₹75.59 B | -1.16% |
| 2023-12-31 | ₹76.47 B | 10.65% |
| 2022-12-31 | ₹69.11 B | 229.88% |
| 2021-12-31 | ₹20.95 B | 15.38% |
| 2020-12-31 | ₹18.15 B | 4.65% |
| 2019-12-31 | ₹17.35 B | 104.9% |
| 2018-12-31 | ₹8.46 B | 44.53% |
| 2017-12-31 | ₹5.85 B | 23.68% |
| 2016-12-31 | ₹4.73 B | 104.16% |
| 2015-12-31 | ₹2.32 B | 152.58% |
| 2014-12-31 | ₹0.91 B | 164.09% |
| 2013-12-31 | ₹0.34 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Isoray
ISR | ₹0.28 B | -99.62% | 🇺🇸 USA |
 OPKO Health
OPK | ₹71.11 B | -4.31% | 🇺🇸 USA |
 Pacific Biosciences
PACB | ₹66.97 B | -9.88% | 🇺🇸 USA |